Literature DB >> 10590411

Mutations in MCT1 cDNA in patients with symptomatic deficiency in lactate transport.

N Merezhinskaya1, W N Fishbein, J I Davis, J W Foellmer.   

Abstract

We identified 5 patients with subnormal erythrocyte lactate transport plus symptoms and signs of muscle injury on exercise and heat exposure. All had transport rates below the 95% envelope for normals. Three cases had rates 40-50% of mean normal. One was found to have a missense mutation in monocarboxylate transporter 1 (MCT1), the gene for the red cell lactate transporter (also expressed in skeletal muscle), at a conserved site, which was not mutated in a cohort of 90 normal humans. The other 2 cases had a different missense mutation (at a nonconserved site), which was also not mutated in the normal cohort. All 3 patients were heterozygotes. We presume that these mutations are responsible for their subnormal lactate transport, and hence their muscle injury under environmental stress; homozygous patients should be more seriously compromised. The other 2 cases had lactate transport rates 60-65% of mean normal, and their MCT1 revealed a third mutation, which proved to be a common polymorphism in the normal cohort. These 2 patients may be physiologic outliers in lactate transport, with their muscle damage arising from some other genetic defect. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10590411     DOI: 10.1002/(sici)1097-4598(200001)23:1<90::aid-mus12>3.0.co;2-m

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  24 in total

Review 1.  Monocarboxylate Transporters: Therapeutic Targets and Prognostic Factors in Disease.

Authors:  R S Jones; M E Morris
Journal:  Clin Pharmacol Ther       Date:  2016-08-22       Impact factor: 6.875

Review 2.  Living on the Edge: Efferocytosis at the Interface of Homeostasis and Pathology.

Authors:  Sho Morioka; Christian Maueröder; Kodi S Ravichandran
Journal:  Immunity       Date:  2019-05-21       Impact factor: 31.745

Review 3.  Multifaceted role of insulin-like growth factors and mammalian target of rapamycin in skeletal muscle.

Authors:  Robert A Frost; Charles H Lang
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-10       Impact factor: 4.741

Review 4.  Short-Chain Fatty Acid Transporters: Role in Colonic Homeostasis.

Authors:  Sathish Sivaprakasam; Yangzom D Bhutia; Shengping Yang; Vadivel Ganapathy
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

5.  Functional characterization of 5-oxoproline transport via SLC16A1/MCT1.

Authors:  Shotaro Sasaki; Yuya Futagi; Masaki Kobayashi; Jiro Ogura; Ken Iseki
Journal:  J Biol Chem       Date:  2014-11-04       Impact factor: 5.157

6.  Presence and localization of three lactic acid transporters (MCT1, -2, and -4) in separated human granulocytes, lymphocytes, and monocytes.

Authors:  Natalya Merezhinskaya; Sunday A Ogunwuyi; Florabel G Mullick; William N Fishbein
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

Review 7.  The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.

Authors:  Andrew P Halestrap; David Meredith
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

8.  A 44-kDa of protein identical to the N-terminal amino acid sequence of MCT1 in human circulation.

Authors:  Kenji Iizuka; Noriteru Morita; Tatsuya Nagai; Akiko Hanada; Koichi Okita; Kazuya Yonezawa; Takeshi Murakami; Akira Kitabatake; Hideaki Kawaguchi
Journal:  Mol Cell Biochem       Date:  2003-06       Impact factor: 3.396

9.  Role of the monocarboxylate transporter MCT1 in the uptake of lactate during active recovery.

Authors:  Rocío Cupeiro; Raúl Pérez-Prieto; Teresa Amigo; Pilar Gortázar; Carlos Redondo; Domingo González-Lamuño
Journal:  Eur J Appl Physiol       Date:  2016-03-29       Impact factor: 3.078

Review 10.  Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

Authors:  Stephen J Fairweather; Nishank Shah; Stefan Brӧer
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.